Fri, Sep 19, 2014, 4:05 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

POZEN Inc. Message Board

  • hofno2003 hofno2003 Aug 20, 2014 10:36 AM Flag

    Pernix 500K Warrants, Exercise Price $4.28; Total Gain Today for POZN $2+ million, will increase to $5-6 million;

    Altough POZN already soldout its Treximet royalty rights to a financial investor, todays deal is a substantial windfall profit for POZN.
    - Pernix lifted its 2015 forecast to $220 million and EbitA to $95 million. This should bring Pernix share price up to $15 (less than 3 times revenue) and at low EPS multiple
    - At $15 per share the exercised warrants make an extraordinary profit at POZN of $ 5 million
    - The exUS treximet rights for all dose strengths are again open for licencing for POZN - this is a big asset. Pernix payed more than $200 million to GSK for the US rights just now - this gives a clue about the deal value possible for POZN with EU and ROW rights!

    Long position in LPCN, RXII, POZN;

    Sentiment: Strong Buy

7.89-0.05(-0.63%)4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.